Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial
Titel:
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial
Auteur:
Schöffski, Patrick Chawla, Sant Maki, Robert G Italiano, Antoine Gelderblom, Hans Choy, Edwin Grignani, Giovanni Camargo, Veridiana Bauer, Sebastian Rha, Sun Young Blay, Jean-Yves Hohenberger, Peter D'Adamo, David Guo, Matthew Chmielowski, Bartosz Le Cesne, Axel Demetri, George D Patel, Shreyaskumar R